Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

Redburn Partners Initiates Coverage On American Airlines Group with Buy Rating

By Benzinga Newsdesk

Today, 8:39 AM

Redburn Partners initiates coverage on American Airlines Group (NASDAQ:AAL) with a Buy rating.

AAL

News

Atossa Therapeutics Adjourns Special Stockholder Meeting To October 7, 2021 To Allow Additional Time To Vote

By Benzinga Newsdesk

Today, 8:39 AM

Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with

ATOS

Jefferies Initiates Coverage On Treehouse Foods with Hold Rating, Announces $52 Price Target

By Benzinga Newsdesk

Today, 8:39 AM

Jefferies analyst Rob Dickerson initiates coverage on Treehouse Foods (NYSE:THS) with a Hold rating and a $52 price…

THS

Splunk Q1 EPS $(0.32) Beats $(0.74) Estimate, Sales $674.00M Beat $628.75M Estimate; Raises Guidance

By Benzinga Newsdesk

Today, 8:39 AM

Splunk (NASDAQ:SPLK) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.74) by 56.76 percent. This is a 64.84 percent increase over losses of $(0.91) per share from the same

SPLK

Context Therapeutics Q2 EPS $(0.25)

Related Posts

Redburn Partners Initiates Coverage On American Airlines Group with Buy Rating

Atossa Therapeutics Adjourns Special Stockholder Meeting To October 7, 2021 To Allow Additional Time To Vote

Jefferies Initiates Coverage On Treehouse Foods with Hold Rating, Announces $52 Price Target

Splunk Q1 EPS $(0.32) Beats $(0.74) Estimate, Sales $674.00M Beat $628.75M Estimate; Raises Guidance